Safeguard Scientifics (SFES)
OTHER OTC:SFES
Top Page
No summary available
Positive Factors
Low Leverage
Low leverage provides financial flexibility and reduces risk, allowing the company to potentially invest in opportunities without the burden of high debt.
Negative Factors
Negative Cash Flow
Persistent negative cash flow indicates poor cash generation, which can limit the company's ability to invest in growth opportunities and meet financial obligations.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage
Low leverage provides financial flexibility and reduces risk, allowing the company to potentially invest in opportunities without the burden of high debt.
Read all positive factors
Safeguard Scientifics (SFES) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$25.34M
Dividend YieldN/A
Average Volume (3M)24.47K
Price to Earnings (P/E)2.9
Beta (1Y)-0.36
Revenue GrowthN/A
EPS Growth12.57%
CountryUS
Employees33
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)-0.62
Shares Outstanding16,722,994
10 Day Avg. Volume67,574
30 Day Avg. Volume24,469
Financial Highlights & Ratios
PEG Ratio-0.84
Price to Book (P/B)1.46
Price to Sales (P/S)0.00
P/FCF Ratio-4.81
Enterprise Value/Market Cap0.73
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-49.59
Enterprise Value/Ebitda-1.87
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Safeguard Scientifics Business Overview & Revenue Model
Company Description
Safeguard Scientifics, Inc. no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage...
How the Company Makes Money
Safeguard Scientifics makes money primarily through the capital appreciation of its investments in portfolio companies. The company's revenue model involves acquiring equity stakes in healthcare, financial services, and digital media companies, an...
Safeguard Scientifics Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -374.00K | -319.00K | -271.00K | -229.00K | -311.00K |
| EBITDA | -10.01M | -9.51M | -13.99M | 27.23M | -37.30M |
| Net Income | -10.38M | -9.83M | -14.26M | 27.00M | -37.62M |
Balance Sheet | |||||
| Total Assets | 11.30M | 22.84M | 37.69M | 54.03M | 69.03M |
| Cash, Cash Equivalents and Short-Term Investments | 6.82M | 9.50M | 20.17M | 29.29M | 15.60M |
| Total Debt | 760.00K | 1.25M | 1.68M | 2.05M | 2.38M |
| Total Liabilities | 1.48M | 2.86M | 3.12M | 3.46M | 6.16M |
| Stockholders Equity | 9.83M | 19.98M | 34.58M | 50.57M | 62.88M |
Cash Flow | |||||
| Free Cash Flow | -2.98M | -3.31M | -3.26M | -8.15M | -8.14M |
| Operating Cash Flow | -2.98M | -3.31M | -3.26M | -8.15M | -8.14M |
| Investing Cash Flow | 285.00K | 5.72M | -4.66M | 58.11M | -1.27M |
| Financing Cash Flow | -9.00K | -6.25M | -3.49M | -40.80M | -40.00K |
Safeguard Scientifics Technical Analysis
Positive
1.52
Price Trends
0.90
Positive
0.84
Positive
0.83
Positive
Market Momentum
0.22
Negative
83.63
Negative
85.22
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SFES, the sentiment is Positive. The current price of 1.52 is above the 20-day moving average (MA) of 1.12, above the 50-day MA of 0.90, and above the 200-day MA of 0.83, indicating a bullish trend. The MACD of 0.22 indicates Negative momentum. The RSI at 83.63 is Negative, neither overbought nor oversold. The STOCH value of 85.22 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SFES.
Safeguard Scientifics Risk Analysis
Safeguard Scientifics disclosed 28 risk factors in its most recent earnings report. Safeguard Scientifics reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 3 New Risks
1.
We have undertaken actions to effect a "going dark" transaction, including delisting our common stock from trading on The Nasdaq Stock Market LLC ("Nasdaq"), terminating the registration of our common stock under Sections 12(b) and 12(g) of the Exchange Act and suspending our reporting obligations under Section 15(d) of the Exchange Act. Q4, 2023
2.
We are managed by a third-party service provider and our success in executing our strategy is dependent on such service provider. Q4, 2023
3.
Non-performance by the subtenant of our previous office space could adversely affect us. Q4, 2023
Safeguard Scientifics Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
| ― | $25.34M | 2.94 | -47.44% | ― | ― | 12.57% | |
| ― | $11.45M | >-0.01 | -109.09% | ― | ― | 60.78% | |
| ― | $1.77B | -0.01 | ― | ― | 2195.36% | -35.59% | |
57 Neutral | $25.40M | -92.56 | 60.02% | ― | ― | ― | |
51 Neutral | $6.81M | -1.17 | -25.88% | 1.07% | 66.65% | -1497.99% | |
44 Neutral | $7.90M | -0.16 | -1438.14% | ― | -62.09% | -99.89% |
* Financial Sector Average
SFES
Safeguard Scientifics
1.52
0.73
93.73%
BTTC
Black Titan
1.26
-2.27
-64.31%
MAAS
Highest Performances Holdings
5.52
-780.18
-99.30%
CWD
CaliberCos, Inc. Class A
1.12
-9.96
-89.89%
GRAN
Grande Group Limited Class A
1.02
-3.77
-78.71%
MLCI
Mount Logan Capital Inc
3.49
-4.48
-56.21%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―